Zoetis Inc (NYSE:ZTS)
$ 169.04 0.91 (0.54%) Market Cap: 77.13 Bil Enterprise Value: 81.93 Bil PE Ratio: 32.57 PB Ratio: 15.27 GF Score: 96/100

Zoetis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 12:00PM GMT
Release Date Price: $161.25 (-0.63%)
David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

Great. So good morning, everybody. On behalf of Morgan Stanley, this is Dave Risinger. I cover both major and specialty pharmaceuticals. And it's very much my pleasure to welcome the 2 leaders of the Zoetis management team this morning.

I do need to refer you to disclaimers at www.morganstanley.com/researchdisclosures. And just note that if you're a member of the press, we ask that you disconnect and reach out to Morgan Stanley Public Relations.

So this morning, I want to welcome Kristin Peck, who is the CEO of Zoetis; and Glenn David, who's Executive Vice President and CFO. And we are going to get right into it.

Questions & Answers

David Reed Risinger
Morgan Stanley, Research Division - MD in Equity Research and United States Pharmaceuticals Analyst

So I guess, to start off, Kristin, so congratulations on the exceptional

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot